See more : ZZLL Information Technology, Inc. (ZZLL) Income Statement Analysis – Financial Results
Complete financial analysis of Nestlé S.A. (NSRGF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nestlé S.A., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Implantica AG (IMP-A-SDB.ST) Income Statement Analysis – Financial Results
- Nippon Concrete Industries Co., Ltd. (5269.T) Income Statement Analysis – Financial Results
- Alligator Energy Limited (AGE.AX) Income Statement Analysis – Financial Results
- PT Bank JTrust Indonesia Tbk (BCIC.JK) Income Statement Analysis – Financial Results
- CIE Automotive India Limited (CIEINDIA.NS) Income Statement Analysis – Financial Results
Nestlé S.A. (NSRGF)
About Nestlé S.A.
Nestlé S.A., together with its subsidiaries, operates as a food and beverage company. The company operates through Zone Europe, Middle East and North Africa; Zone Americas; and Zone Asia, Oceania and sub-Saharan Africa segments. It offers baby foods under the Cerelac, Gerber, Nido, and NaturNes brands; bottled water under the Nestlé Pure Life, Perrier, and S.Pellegrino brands; cereals under the Fitness, Nesquik, cheerios, and Lion Cereals brands; and chocolate and confectionery products under the KitKat, Nestle L'atelier, Nestle Toll House, Milkybar, Smarties, Quality Street, Aero, Garoto, Orion, and Cailler brands. The company also provides coffee products under the Nescafé, Nespresso, Nescafé Dolce Gusto, Starbucks Coffee At Home, and Blue Bottle Coffee brands; culinary, chilled, and frozen foods under the Maggi, Hot Pockets, Stouffer's, Thomy, Jacks, TombStone, Herta, Buitoni, DiGiorno, and Lean Cuisine brands; dairy products under the Carnation, Nido, Coffee-Mate, and La Laitière brands; and drinks under the Nesquik, Nestea, Nescafé, and Milo brands. In addition, it offers food service products under the Milo, Nescafé, Maggi, Chef, Nestea, Stouffer's, Chef-Mate, Sjora, Minor's, and Lean Cuisine brand names; healthcare nutrition products under the Boost, Peptamen, Resource, Optifast, and Nutren Junior brands; ice cream products under the Dreyer's, Mövenpick, Häagen-Dazs, Nestlé Ice Cream, and Extrême brands; and pet care products under the Purina, ONE, Alpo, Felix, Pro Plan, Cat Chow, Fancy Feast, Bakers, Friskies, Dog Chow, Beneful, and Gourmet brands. The company was founded in 1866 and is headquartered in Vevey, Switzerland.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 93.35B | 94.78B | 87.47B | 84.68B | 92.87B | 91.75B | 90.12B | 89.79B | 89.08B | 91.87B | 92.37B | 92.32B | 83.77B | 104.61B | 100.58B | 109.91B | 107.55B | 98.46B | 91.08B | 86.77B | 87.98B | 89.16B | 84.70B | 81.42B | 74.66B | 71.75B |
Cost of Revenue | 50.33B | 51.75B | 45.47B | 42.97B | 46.65B | 46.07B | 44.92B | 44.20B | 44.73B | 47.55B | 48.11B | 48.40B | 44.13B | 44.78B | 43.47B | 47.34B | 45.04B | 40.71B | 37.95B | 36.15B | 37.58B | 38.52B | 37.76B | 38.12B | 35.91B | 35.96B |
Gross Profit | 43.02B | 43.04B | 42.00B | 41.71B | 46.22B | 45.68B | 45.20B | 45.59B | 44.35B | 44.31B | 44.26B | 43.93B | 39.64B | 59.84B | 57.11B | 62.57B | 62.52B | 57.75B | 53.13B | 50.62B | 50.40B | 50.64B | 46.94B | 43.30B | 38.75B | 35.78B |
Gross Profit Ratio | 46.09% | 45.41% | 48.02% | 49.26% | 49.77% | 49.79% | 50.15% | 50.77% | 49.79% | 48.24% | 47.92% | 47.58% | 47.32% | 57.20% | 56.78% | 56.93% | 58.13% | 58.65% | 58.34% | 58.34% | 57.28% | 56.80% | 55.42% | 53.18% | 51.90% | 49.88% |
Research & Development | 1.66B | 1.70B | 1.67B | 1.58B | 1.67B | 1.69B | 1.72B | 1.74B | 1.68B | 1.63B | 1.50B | 1.54B | 1.42B | 1.40B | 1.36B | 1.98B | 1.88B | 1.73B | 1.50B | 1.41B | 1.21B | 1.21B | 1.16B | 1.04B | 893.00M | 807.00M |
General & Administrative | 17.60B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.05B | 7.10B | 7.11B | 29.37B | 26.47B | 23.89B | 22.47B |
Selling & Marketing | 7.77B | 25.24B | 25.21B | 25.23B | 28.29B | 28.47B | 28.75B | 29.54B | 28.64B | 27.87B | 27.87B | 27.86B | 25.00B | 44.40B | 42.53B | 44.92B | 45.62B | 42.71B | 39.91B | 31.20B | 31.08B | 7.11B | 6.42B | 5.88B | 5.27B | 4.89B |
SG&A | 25.31B | 25.24B | 25.21B | 25.23B | 28.29B | 28.47B | 28.75B | 29.54B | 28.64B | 27.87B | 27.87B | 27.86B | 25.00B | 44.40B | 42.53B | 44.92B | 45.62B | 42.71B | 39.91B | 38.24B | 38.19B | 7.11B | 35.79B | 32.35B | 29.16B | 27.35B |
Other Expenses | 1.99B | -252.00M | -166.00M | -146.00M | -156.00M | -58.00M | -88.00M | -57.00M | -48.00M | -66.00M | -159.00M | -88.00M | -130.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -699.00M | -534.00M | 1.69B | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 28.96B | 26.98B | 26.81B | 27.28B | 30.03B | 30.22B | 30.31B | 31.27B | 30.46B | 30.13B | 28.95B | 29.43B | 26.49B | 47.70B | 44.62B | 39.59B | 47.30B | 44.96B | 42.33B | 41.25B | 40.96B | 41.98B | 37.45B | 33.80B | 30.43B | 28.46B |
Cost & Expenses | 79.29B | 78.72B | 72.27B | 70.25B | 76.68B | 76.29B | 75.23B | 75.47B | 75.19B | 77.69B | 77.06B | 77.82B | 70.61B | 92.47B | 88.09B | 86.93B | 92.34B | 85.67B | 80.28B | 77.40B | 78.54B | 80.50B | 75.21B | 71.92B | 66.34B | 64.42B |
Interest Income | 283.00M | 210.00M | 80.00M | 106.00M | 200.00M | 247.00M | 152.00M | 121.00M | 101.00M | 135.00M | 219.00M | 110.00M | 87.00M | 58.00M | 83.00M | 102.00M | 418.00M | 0.00 | 0.00 | 421.00M | 608.00M | 745.00M | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 1.64B | 1.25B | 951.00M | 983.00M | 1.21B | 1.01B | 766.00M | 753.00M | 722.00M | 761.00M | 848.00M | 591.00M | 527.00M | 828.00M | 745.00M | 1.10B | 1.48B | 0.00 | 0.00 | 669.00M | 1.20B | 1.41B | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 3.46B | 3.54B | 3.44B | 3.47B | 3.71B | 3.92B | 3.93B | 3.13B | 3.18B | 3.06B | 3.17B | 3.15B | 2.93B | 3.18B | 3.37B | 3.25B | 3.21B | 3.06B | 2.73B | 4.38B | 4.23B | 2.54B | 2.58B | 2.74B | 2.60B | 2.91B |
EBITDA | 17.80B | 16.08B | 15.20B | 18.37B | 19.17B | 17.92B | 14.24B | 16.41B | 15.68B | 14.09B | 16.45B | 16.53B | 15.51B | 15.39B | 15.95B | 14.63B | 18.21B | 16.58B | 13.68B | 13.29B | 13.14B | 11.21B | 11.89B | 12.24B | 10.91B | 9.91B |
EBITDA Ratio | 19.07% | 19.96% | 20.61% | 20.61% | 20.64% | 20.65% | 16.80% | 19.01% | 18.84% | 16.75% | 19.94% | 19.13% | 19.29% | 14.70% | 15.82% | 23.94% | 16.89% | 16.10% | 14.85% | 15.05% | 15.62% | 12.57% | 14.58% | 15.41% | 15.16% | 14.58% |
Operating Income | 14.06B | 12.33B | 11.68B | 14.80B | 16.08B | 13.75B | 10.11B | 13.16B | 12.41B | 10.91B | 13.07B | 13.93B | 12.47B | 11.38B | 11.84B | 21.83B | 14.43B | 12.11B | 10.23B | 8.67B | 8.90B | 8.66B | 9.22B | 9.19B | 7.91B | 7.10B |
Operating Income Ratio | 15.06% | 13.00% | 13.35% | 17.47% | 17.31% | 14.99% | 11.22% | 14.66% | 13.93% | 11.87% | 14.15% | 15.09% | 14.89% | 10.88% | 11.77% | 19.86% | 13.42% | 12.29% | 11.23% | 9.99% | 10.12% | 9.72% | 10.88% | 11.28% | 10.60% | 9.90% |
Total Other Income/Expenses | -1.36B | -1.04B | -873.00M | -874.00M | -1.02B | -761.00M | -696.00M | -637.00M | -624.00M | -637.00M | -631.00M | -481.00M | -421.00M | -762.00M | 0.00 | 0.00 | -916.00M | -681.00M | 0.00 | -854.00M | -594.00M | -665.00M | -542.00M | -845.00M | -1.06B | -979.00M |
Income Before Tax | 12.70B | 11.29B | 10.81B | 13.92B | 15.06B | 12.99B | 9.49B | 12.53B | 11.78B | 10.27B | 12.44B | 13.45B | 12.05B | 11.38B | 11.84B | 21.83B | 13.52B | 12.11B | 10.23B | 8.00B | 8.31B | 9.68B | 8.77B | 8.34B | 6.86B | 6.12B |
Income Before Tax Ratio | 13.61% | 11.91% | 12.35% | 16.44% | 16.22% | 14.16% | 10.53% | 13.95% | 13.23% | 11.18% | 13.46% | 14.57% | 14.38% | 10.88% | 11.77% | 19.86% | 12.57% | 12.29% | 11.23% | 9.22% | 9.44% | 10.86% | 10.35% | 10.24% | 9.19% | 8.53% |
Income Tax Expense | 2.31B | 2.73B | 2.26B | 3.37B | 3.16B | 3.44B | 2.78B | 4.41B | 3.31B | 3.37B | 3.26B | 3.45B | 3.11B | 3.34B | 3.09B | 3.79B | 3.42B | 3.29B | 2.60B | 2.45B | 2.31B | 2.30B | 2.43B | 2.76B | 2.31B | 2.00B |
Net Income | 11.21B | 9.27B | 16.91B | 12.23B | 12.61B | 10.14B | 7.16B | 8.53B | 9.07B | 14.46B | 10.02B | 10.23B | 9.49B | 34.23B | 10.43B | 18.04B | 10.65B | 9.20B | 8.08B | 7.03B | 6.21B | 7.56B | 6.68B | 5.76B | 4.72B | 4.21B |
Net Income Ratio | 12.01% | 9.78% | 19.33% | 14.44% | 13.58% | 11.05% | 7.94% | 9.50% | 10.18% | 15.74% | 10.84% | 11.08% | 11.33% | 32.72% | 10.37% | 16.41% | 9.90% | 9.34% | 8.87% | 8.10% | 7.06% | 8.48% | 7.89% | 7.08% | 6.33% | 5.86% |
EPS | 4.23 | 3.42 | 6.06 | 4.30 | 4.30 | 3.36 | 2.31 | 2.76 | 2.90 | 4.54 | 3.14 | 3.21 | 2.97 | 10.16 | 2.92 | 4.87 | 2.78 | 2.39 | 2.08 | 1.70 | 1.61 | 1.95 | 1.73 | 1.49 | 6.11 | 5.35 |
EPS Diluted | 4.23 | 3.42 | 6.06 | 4.29 | 4.30 | 3.36 | 2.31 | 2.75 | 2.89 | 4.52 | 3.13 | 3.20 | 2.96 | 10.12 | 2.91 | 4.84 | 2.76 | 2.38 | 2.06 | 1.67 | 1.59 | 1.93 | 1.71 | 1.48 | 6.04 | 5.30 |
Weighted Avg Shares Out | 2.65B | 2.71B | 2.79B | 2.85B | 2.93B | 3.01B | 3.09B | 3.09B | 3.13B | 3.19B | 3.19B | 3.19B | 3.20B | 3.37B | 3.57B | 3.70B | 3.83B | 3.85B | 3.89B | 3.88B | 3.87B | 3.88B | 3.87B | 8.07B | 8.07B | 8.07B |
Weighted Avg Shares Out (Dil) | 2.65B | 2.71B | 2.79B | 2.85B | 2.93B | 3.02B | 3.10B | 3.10B | 3.14B | 3.20B | 3.20B | 3.20B | 3.21B | 3.38B | 3.58B | 3.73B | 3.87B | 3.89B | 4.00B | 4.04B | 4.04B | 4.04B | 3.90B | 8.07B | 8.07B | 8.07B |
UK watchdog dials down baby formula probe
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
Nestle Is A Buy After Real Growth Is Back
Nestlé in ‘uncharted waters' warn Barclays analysts
Nestlé tumbles after KitKat maker slashes sales guidance by a quarter
Nestle, Mars Wrigley, Ferrero back EU deforestation law, document shows
24 Barron's Pro-Picked 2024 Mid-Year Dividend Dogs: Buy 2 In July
Nestlé: Discounted Against Historical Valuation, Buy For Long-Term Play
Nestle sees stable sales growth from Q2, CEO tells paper
Nestle launches website for individuals on weight loss drugs
Source: https://incomestatements.info
Category: Stock Reports